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Background:  Cardiac surgery in high-risk patients (pts) with adult congenital heart disease (ACHD) may require mechanical circulatory 
support (MCS) such as extracorporeal membrane oxygenation (ECMO) or intra-aortic balloon pump (IABP) in the post-operative period. 
methods:  We reviewed records for all ACHD pts who required MCS following cardiotomy from 1/2001-12/2013.
results:  During the study period, 4,220 operations were performed in ACHD pts at our institution, of whom 25 (0.6%) required 
postoperative MCS (15 males; median age 41 yrs, range 19-75; median past sternotomies 2 [1-4]). Pre-operatively, mean systemic 
ventricular EF was 47% (range 10-66%); 68% of pts were in NYHA class IV heart failure. Underlying diagnoses included pulmonary 
atresia with intact ventricular septum (24%), tetralogy of Fallot (16%), Ebstein anomaly (12%), cc-TGA (12%), and septal defects (12%), 
with tricuspid atresia, truncus arteriosus and congenital valve abnormalities constituting the remaining diagnoses (24%). The most 
common operations performed were valvular operations with/without maze (52%), Fontan conversion (20%), coronary bypass grafting 
with valvular operations (12%), and heart transplant (8%). Indications for MCS were left-sided (systemic) heart failure (32%), right-sided 
(sub-pulmonary) heart failure (24%), biventricular heart failure (36%), persistent arrhythmia (4%) and hypoxemia (4%). Both ECMO and 
IABP were used in 68% of pts, while 32% used ECMO only. The mean duration of MCS was 195.8 hrs (range 20-850). Common early 
morbidities included coagulopathy (60%), renal failure (56%) and arrhythmia (48%). Overall, 48% of pts survived to hospital discharge. 
All deaths were due to either multi organ failure or the underlying cardiac diagnoses, with one pt dying from overwhelming sepsis. Median 
available follow up for survivors was 38.5 months (max 106 months). New York Heart Association functional class was I/II in 6/9(67%) late 
survivors in whom close follow up was available.
Conclusion:  Following complex operations in high-risk ACHD pts, MCS may be required. Despite significant morbidity, nearly half of pts 
survive to hospital discharge with good functional status at late follow up. 
